- Healthcare
- Social
- Retail
- Main
You are not logged in!
Do you want to login? It's free!
Who do you implu? Create a Free Account!
Attachment 1
|
OMB
APPROVAL
|
|
|
OMB Number:
Expires:
|
3235-0060
April 30, 2009
|
|
Estimated
average burden
hours
per
response …5.0
|
|
UNITED
STATES
SECURITIESANDEXCHANGECOMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
|
Date
of Report (Date of earliest event reported)
|
October
20, 2008
|
|
APPLIED
NANOTECH HOLDIINGS, INC.
|
|
(Exact
name of registrant as specified in its
charter)
|
|
TEXAS
|
1-11602
|
76-0273345
|
|
(State
or other jurisdiction
of
incorporation)
|
(Commission
File
Number)
|
(IRS
Employer
Identification
No.)
|
|
3006
Longhorn Boulevard, Suite 107, Austin, Texas
|
78758
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
|
(512)
339 - 5020
|
|
Registrant’s
telephone number, including area
code
|
|
(Former
name or former address, if changed since last
report.)
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a
-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d
-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e
-4(c))
Item
5.02 Departure of Directors or Principal Officers; Election of
Directors; Appointment of Principal Officers.
Effective
October 20, 2007, Bradford Lamb resigned as a member of the Board of Directors
of the Company. Mr. Lamb’s resignation is not in connection with any
disagreement with the Company on any matter relating to our operations,
policies, or practices. Mr. Lamb was a member of the audit committee and the
compensation committee. On the same date, the Board appointed Clinton J. Everton
to fill the vacancy for the remainder of Mr. Lamb’s term. Mr. Everton has not
yet been appointed to any committees.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits:
99.1
Press Released dated October 23, 2008
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
Applied
Nanotech Holdings, Inc.
|
|
|
|
|
|
By:
/s/ Douglas P.
Baker
|
|
|
Date:
October 23, 2007
|
Douglas
P. Baker
Chief
Financial Officer
|